Abbott Communications finally launched on Y&R, and it's still completely pointless. What exactly is Sally Spectra even the ...

Shares of Abbott Laboratories tumbled Thursday after the medical devices maker posted fourth-quarter earnings and sales that ...

Intel shares rise slightly ahead of the chip maker’s fourth-quarter earnings, due out after the close of trading Thursday.

Q4 2025 Management View CEO Robert Ford highlighted that 2025 showcased "Abbott's leadership in innovation, disciplined execution and strategic actions taken to position the company for sustainable ...

Abbott’s stock has fallen by over 7% despite reporting strong fiscal year 2025 (FY25) revenues of $44.32bn, representing a ...

The company's full-year 2025 revenues rose 6 percent year over year, with a 4 percent decline in diagnostics for the year.

The medical device maker announced it anticipates first quarter adjusted profits per share between $1.12 and $1.18, trailing ...

Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the ...